Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Core Scientific (CORZ) EBT Margin (2021 - 2025)

Historic EBT Margin for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to 180.68%.

  • Core Scientific's EBT Margin rose 2966200.0% to 180.68% in Q3 2025 from the same period last year, while for Sep 2025 it was 229.65%, marking a year-over-year decrease of 65200.0%. This contributed to the annual value of 257.34% for FY2024, which is 2084100.0% down from last year.
  • Latest data reveals that Core Scientific reported EBT Margin of 180.68% as of Q3 2025, which was up 2966200.0% from 1191.23% recorded in Q2 2025.
  • In the past 5 years, Core Scientific's EBT Margin ranged from a high of 730.46% in Q1 2025 and a low of 1191.23% during Q2 2025
  • Its 5-year average for EBT Margin is 178.7%, with a median of 137.64% in 2023.
  • Over the last 5 years, Core Scientific's EBT Margin had its largest YoY gain of 6128300bps in 2025, and its largest YoY loss of -6209000bps in 2025.
  • Core Scientific's EBT Margin (Quarter) stood at 25.5% in 2021, then plummeted by -1576bps to 376.36% in 2022, then surged by 63bps to 137.64% in 2023, then crashed by -103bps to 279.34% in 2024, then skyrocketed by 35bps to 180.68% in 2025.
  • Its EBT Margin was 180.68% in Q3 2025, compared to 1191.23% in Q2 2025 and 730.46% in Q1 2025.